Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Cancer Reports (Hoboken, N.J.)|July 11, 2026
Metronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI-Integrated Future StrategiesRavi Chauhan, Suraja Kumar Das, Lakshay Malhotra, et al.
The Journal of Biological Chemistry|June 28, 2012
Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progressionShakur Mohibi, Channabasavaiah Basavaraju Gurumurthy, Alo Nag, et al.
Molecular Therapy. Nucleic Acids|March 13, 2020
Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion TranscriptsNeetha Nanoth Vellichirammal, Abrar Albahrani, Jasjit K Banwait, et al.
Journal of the National Cancer Center|March 5, 2025
Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer linkAlanoud Abdulla, Hana Q Sadida, Jayakumar Jerobin, et al.
Breast Cancer Research and Treatment|January 5, 2013
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patientsSameer Mirza, Emad A Rakha, Alaa Alshareeda, et al.
Oncogene|September 4, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysisMohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Molecular and Cellular Biology|May 4, 2021
The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA ExportIrfana Saleem, Sameer Mirza, Aniruddha Sarkar, et al.
Medcomm|July 23, 2026
Tumor Plasticity and Microenvironmental Crosstalk as Drivers of Metastasis and Therapy ResistanceGunjan Dagar, Manisha Dagar, Ashna Gupta, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysisBenjamin B Kennedy, Mohsin Raza, Sameer Mirza, et al.
Tissue Barriers|April 14, 2026
Integrated transcriptomic and functional characterization of Claudin-1 reveals its oncogenic and immunomodulatory roles in pancreatic ductal adenocarcinomaAnju Surendranath, Yogain Taank, Saira Hamid, et al.
Pageof 7